These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7518275)

  • 1. Enhanced tenascin immunoreactivity in leukoplakia and squamous cell carcinoma of the oral cavity: an immunohistochemical study.
    Shrestha P; Sakamoto F; Takagi H; Yamada T; Mori M
    Eur J Cancer B Oral Oncol; 1994; 30B(2):132-7. PubMed ID: 7518275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular localization of tenascin in squamous cell carcinoma of oral cavity: an immunohistochemical study.
    Mori M; Muramatsu Y; Yamada K; Shrestha P; Takai Y
    Anticancer Res; 1996; 16(5B):3075-9. PubMed ID: 8920770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma.
    Tiitta O; Happonen RP; Virtanen I; Luomanen M
    J Oral Pathol Med; 1994 Nov; 23(10):446-50. PubMed ID: 7532219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tenascin in hamster buccal pouch mucosa during experimental carcinogenesis.
    Lee SK; Park SC; Chi JG; Sakamoto F; Shrestha P; Mori M
    Eur J Cancer B Oral Oncol; 1995 May; 31B(3):188-92. PubMed ID: 7549759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential.
    Harada T; Shinohara M; Nakamura S; Oka M
    Virchows Arch; 1994; 424(3):257-66. PubMed ID: 7514477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin expression in normal and abnormal human endometrium.
    Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
    Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of Tenascin in embryogenesis, tumorigenesis and inflammatory oral mucosa.
    Mane DR; Kale AD; Naik VV
    Arch Oral Biol; 2011 Jul; 56(7):655-63. PubMed ID: 21208610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
    Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
    Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin expression in basal cell carcinoma.
    Verstraeten AA; Mackie EJ; Hageman PC; Hilgers J; Schol DJ; De Jongh GJ; Schalkwijk J
    Br J Dermatol; 1992 Dec; 127(6):571-4. PubMed ID: 1282358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.
    Sunaga H; Fujieda S; Tsuzuki H; Asamoto K; Fukuda M; Saito H
    Anticancer Res; 2001; 21(4B):2901-6. PubMed ID: 11712784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in expression of basement membrane proteins during tumour progression in oral mucosa.
    Kannan S; Balaram P; Chandran GJ; Pillai MR; Mathew B; Nalinakumari KR; Nair MK
    Histopathology; 1994 Jun; 24(6):531-7. PubMed ID: 8063281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach.
    Tiitta O; Sipponen P; Gould V; Virtanen I
    Virchows Arch; 1994; 425(4):369-74. PubMed ID: 7529617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes.
    Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
    Br J Cancer; 1995 Jul; 72(1):189-92. PubMed ID: 7541237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining of tenascin in Warthin's tumor and in oncocytoma.
    Sunardhi-Widyaputra S; Van Damme B
    Oral Surg Oral Med Oral Pathol; 1993 Sep; 76(3):325-9. PubMed ID: 7690924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma.
    Häkkinen L; Kainulainen T; Salo T; Grenman R; Larjava H
    Oral Dis; 1999 Jul; 5(3):210-7. PubMed ID: 10483066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valuation of exfoliative cytology as prediction factor in oral mucosa lesions.
    Brunotto M; Zárate AM; Cismondi A; Fernández Mdel C; Noher de Halac RI
    Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E92-102. PubMed ID: 15995578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin in human neoplasia.
    Shrestha P; Kusakabe M; Mori M
    Int J Oncol; 1996 Apr; 8(4):741-55. PubMed ID: 21544422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis.
    Wallace WA; Howie SE; Lamb D; Salter DM
    J Pathol; 1995 Apr; 175(4):415-20. PubMed ID: 7540684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.